Monthly Archives: February 2011

DC Jr Committee Event: Cocktails for a Cause

The District of Columbia Junior Advisory invites you to attend the Cocktails for a Cause Happy Hour on Friday, March 18, 2011 from 6 p.m. – 11 p.m. Enjoy drink specials and a chance to win several raffle prizes, including … Continue reading 

Posted in Events | Leave a comment

DC Jr. Committee Event: VA Gold Cup

Posted in Events | Leave a comment

Upcoming Webinar: Getting Involved with Partner Members

Robin Cohen OCNA Board member and Partner Member Sue Ellen Moore OCNA Board member and Partner Member TO REGISTER, please click here.

Posted in Events | Leave a comment

Upcoming Webinar: Ovarian Cancer – What’s Basic? What’s New?

Dr. Robert Coleman Professor, Department of Gynecologic Oncology, MD Anderson Cancer Center TO REGISTER, click here.

Posted in Events | Leave a comment

Action Alert: Tell Congress Not to Cut Ovarian Cancer Funding

The budget being proposed by Congress is harmful to cancer patients. While some politicians and pundits believe the government is spending too much money, it is up to us to tell Congress where our priorities lie. We cannot afford to … Continue reading 

Posted in Blog | Leave a comment

Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations

A new study shows that ovarian cancer patients who had the non-Askenazi Jewish BRCA mutation had longer Progression Free Surivival time and Overall Survival times than ovairan cancer patients who did not have any BRCA mutations.  See abstract here

Posted in News | Tagged , , | Leave a comment

Results of a Third Phase III Trial of Avastin in Ovarian Cancer Released

Genentech, a member of the Roche group, announced that a third Phase III trial of Avastin in ovarian cancer met its endpoint of improvement in progression free survivial.  See the company’s release here

Posted in News | Tagged , , | Leave a comment

Ovarian cancer spread missed when recommended staging biopsies not performed, UC Davis researchers find

UC Davis researchers have found that “[m]ore than a quarter of women with apparent early ovarian cancer do not receive the lymph node biopsies proven to improve patient survival”.  Their analysis of more than 700 ovarian cancer patients in New … Continue reading 

Posted in News | Tagged , , | Leave a comment

February Newsletter

Greetings, With record snowfalls across much of the country last week, many of you may be looking forward to the promise of spring. Here at the Ovarian Cancer National Alliance, we’re anticipating spring, too–and our many upcoming events and activities … Continue reading 

Posted in Blog, Newsletter | Leave a comment

Partner Member Profile: Laura Stecher, Ovarian Cancer Orange County Alliance, Orange County, California

Laura Stecher founded the Ovarian Cancer Orange County Alliance (OCOCA) in 2003 with friends from her support group. Today, she is a ten-year survivor—and one of only three surviving from their original group of eight. Whenever Laura gets burned out … Continue reading 

Posted in Blog | 1 Comment

Update on Medicare Coverage for Avastin (bevacizumab)

Months ago, we told you about a Medicare contractor who was denying coverage of Avastin for patients with ovarian cancer. The Ovarian Cancer National Alliance has worked with Members of Congress and Centers for Medicare and Medicaid Services (CMS) to … Continue reading 

Posted in Blog, News | Tagged , , , , | 1 Comment

New clinical trial to determine ovarian cancer risks in African-American women

University Hospitals Case Medical Center and Case Western Reserve University School of Medicine are conducting an important new study addressing the lack of knowledge about causes and risk factors for ovarian cancer in African American women. The five-year study is … Continue reading 

Posted in News | Tagged | 1 Comment